

HY-P1663A · 5 mg
MedChemExpress · Cat: HY-P1663A
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ATWLPPR_Peptide_TFA.html
Description
ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis. ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes.







